Treating mental health conditions with psilocybin is quickly becoming mainstream. But the experience of Albert Yu-Min Lin shows its potential for physical conditions, too.
/PRNewswire/ - MYND Life Sciences Inc. (CSE: MYND) ("MYND"), a drug research and development company focused on novel psychedelic drug development, diagnostic.
MYND Life Sciences Inc. Establishes Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Birch Aquarium to reopen with outdoor exhibits Feb. 27
After almost three months of closure, Birch Aquarium at the Scripps Institution of Oceanography in La Jolla announced it will open to the public outdoors-only beginning Saturday, Feb. 27. A members-only day is scheduled for Feb. 26.
The aquarium’s outdoor spaces have been enhanced with new animals and activities and will be open to guests with discounted ticket prices. Birch has been closed since early December because of COVID-19 restrictions.
Activities include Preuss Tide Pool Plaza experiences, Kelp Cam viewing on a big screen, an outdoor version of the Oddities exhibit, touch tidepools, shark teeth and specimens and nurseries for baby animals found in local waters.
$1.3 million grant funds clinical trial to test psilocybin for treating patients with phantom limb pain
The Psychedelics and Health Research Initiative (PHRI) at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.
Psilocybin is a naturally occurring psychedelic compound produced by many species of fungus, including so-called magic mushrooms. Phantom limb pain is pain originating from parts of the body no longer present, such as an amputated arm or leg. It is a form of neuropathic pain that actually originates in the spinal cord and brain.